Log In: Homebuilders like DR Horton (+88%) benefited from low unemployment and interest rates.
According to Forbes , these were the leaders based on total yearly return:
: +97% return. Breakthroughs in cystic fibrosis treatments powered long-term sales projections.
At the start of the year, major outlets like Yahoo Finance and CNBC highlighted several picks for growth and stability: :
AI responses may include mistakes. For financial advice, consult a professional. Learn more
: Biotech firms like Nektar Therapeutics (+387%) and Dynavax Technologies (+373%) saw some of the highest individual returns of the year.
Select your city
